Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More
Humana Inc. (NYSE HUM) and USAA Life Insurance Company (USAA Life) today reaffirm their shared commitment to veterans’ well-being with the continuation of co-branded Medicare Advantage plans for 2026 – with new mental health benefits to help elevate behavioral health as a cornerstone of aging with dignity and strength.
Shares of health insurance company Humana (NYSE:HUM)
jumped 2.3% in the morning session after the company announced a new initiative with Providence, a Washington-based health system, to streamline and secure data exchange in support of value-based care. The collaboration aimed to create a scalable system for seamless data sharing, enabling clinicians to deliver more effective care while reducing administrative tasks for members. Humana's President of Insurance, George Renaudin, stated that the effort would help members spend less time on paperwork and more time on their health.
Humana Inc. (NYSE: HUM) and Providence, a Washington-based health system, today announced a pioneering initiative to streamline and secure data exchange between payers and providers – setting a new standard for interoperability in support of value-based care.
Over the past six months, Humana’s shares (currently trading at $262.25) have posted a disappointing 8.2% loss, well below the S&P 500’s 26.5% gain. This might have investors contemplating their next move.
Shares of health insurance company Humana (NYSE:HUM)
fell 3.8% in the afternoon session after the company lost a key lawsuit aimed at reversing cuts to Medicare bonus payments and received a new "sell" rating from Goldman Sachs.
Wall Street edged higher Tuesday as strong bank earnings lifted sentiment, even as renewed U.S.-China trade tensions kept investor enthusiasm in check.
Bloomberg reported on Tuesday that a Texas judge ruled in favor of the federal government, affirming a downgrade of quality ratings that are tied to payments for Medicare Advantage.
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced its ambition to become a national leader in addressing seniors’ emotional health. More than one in four seniors (29%) report being socially isolated, increasing their risk of dementia (by 50%) and self-harm. The Foundation’s 2025 program and research grants—totaling over $12 million—tackle loneliness, illness and other community and cultural drivers of poor emotional health with interventions tested regionally and deployed nationwide.
Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2025 (3Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 5, 2025. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session.
October 9, 2025 - Duos, a digital health company dedicated to empowering older adults to live independently, today announced a monumental $130 million strategic growth equity investment. This substantial funding round, spearheaded by FTV Capital with additional participation from early institutional investor Forerunner Ventures, marks a pivotal moment for the
